A 66-year-old man has become the fourth person in the world to receive a genetically edited pig kidney transplant, performed ...

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the United States.

Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...

The transplant, part of a three-person compassionate use study, used a pig kidney with 69 gene edits provided by US-based biotech eGenesis. The company received the go-ahead from the US Food and ...

David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

The FDA has given approval for the first clinical trials of pig kidney transplants in humans, representing a significant advancement in addressing the organ shortage crisis.

Another patient has received a transplant with a genetically modified pig kidney. Tim Andrews, a 66-year-old who lives in ...

The surgery comes at a turning point in the quest to tell if animal-to-human transplants could help ease the shortage of ...

The clinical trial, which is using pig kidneys developed by eGenesis, is one of numerous FDA-approved studies exploring the potential of using animal organs in human patients. Another trial ...